M. Sciandra

发表

Evaluation of the Mean Corpuscular Volume of Peripheral Blood Mononuclear Cells of HIV Patients by a Coulter Counter To Determine Intracellular Drug Concentrations

Marco Siccardi, Stefano Bonora, G. di Perri, 2011, Antimicrobial Agents and Chemotherapy.

A HPLC-MS method for the simultaneous quantification of fourteen antiretroviral agents in peripheral blood mononuclear cell of HIV infected patients optimized using medium corpuscular volume evaluation.

G. di Perri, A. D’Avolio, M. Siccardi, 2011, Journal of pharmaceutical and biomedical analysis.

UHPLC–MS/MS method with sample dilution to test therapeutic adherence through quantification of ten antihypertensive drugs in urine samples

G. di Perri, F. Veglio, P. Mulatero, 2017, Journal of pharmaceutical and biomedical analysis.

Precision and Accuracy of a Procedure for Detecting Recent Human Immunodeficiency Virus Infections by Calculating the Antibody Avidity Index by an Automated Immunoassay-Based Method

C. Galli, P. Pezzotti, G. Rezza, 2002, Journal of Clinical Microbiology.

Durability of different initial regimens in HIV-infected patients starting antiretroviral therapy with CD4+ counts <200 cells/mm3 and HIV-RNA >5 log10 copies/mL.

A. d’Arminio Monforte, F. Ceccherini‐Silberstein, G. Ippolito, 2019, The Journal of antimicrobial chemotherapy.

Inosine Triphosphatase Polymorphisms and Ribavirin Pharmacokinetics as Determinants of Ribavirin-Associate Anemia in Patients Receiving Standard Anti-HCV Treatment

M. Rizzetto, G. di Perri, A. Calcagno, 2012, Therapeutic drug monitoring.

Longitudinal analysis of HIV-1 coreceptor tropism by single and triplicate HIV-1 RNA and DNA sequencing in patients undergoing successful first-line antiretroviral therapy

A. d’Arminio Monforte, F. Ceccherini‐Silberstein, G. Ippolito, 2013, The Journal of antimicrobial chemotherapy.

Asymptomatic women at high risk of vertical HIV‐1 transmission to their fetuses

P. Tovo, C. Tibaldi, A. Sinicco, 1993 .

The influence of cytomegalovirus on the natural history of HIV infection: evidence of rapid course of HIV infection in HIV-positive patients infected with cytomegalovirus.

A. Maiello, R. Raiteri, A. Sinicco, 1997, Scandinavian journal of infectious diseases.

Incidence and risk factors for liver enzyme elevation among naive HIV-1-infected patients receiving ART in the ICONA cohort.

A. d’Arminio Monforte, F. Ceccherini‐Silberstein, G. Ippolito, 2019, The Journal of antimicrobial chemotherapy.

Pharmacokinetic and pharmacodynamic determinants of early virological response to enfuvirtide-based regimens in HIV-positive patients.

A. Lazzarin, G. di Perri, A. Calcagno, 2008, The Journal of antimicrobial chemotherapy.

Cytokine network and acute primary HIV‐1 infection

R. Raiteri, A. Sinicco, M. Sciandra, 1993, AIDS.

The presence of anti-Tat antibodies is predictive of long-term nonprogression to AIDS or severe immunodeficiency: findings in a cohort of HIV-1 seroconverters.

M. Ciccozzi, A. Scoglio, A. Caputo, 2005, The Journal of infectious diseases.

Metabolic disorders in a cohort of patients treated with highly aggressive antiretroviral therapies during primary HIV-1 infection.

A. Lazzarin, G. Tambussi, G. Tambussi, 2000, AIDS (London).

A validated HPLC-MS method for quantification of the CCR5 inhibitor maraviroc in HIV+ human plasma.

G. di Perri, A. D’Avolio, S. Bonora, 2014, Journal of pharmaceutical and biomedical analysis.

A Validated High-Performance Liquid Chromatography-Ultraviolet Method for Quantification of the CCR5 Inhibitor Maraviroc in Plasma of HIV-Infected Patients

G. di Perri, A. D’Avolio, M. Siccardi, 2010, Therapeutic drug monitoring.

Development, Validation, and Routine Application of a High-Performance Liquid Chromatography Method Coupled with a Single Mass Detector for Quantification of Itraconazole, Voriconazole, and Posaconazole in Human Plasma

F. D. De Rosa, G. di Perri, A. D’Avolio, 2010, Antimicrobial Agents and Chemotherapy.

Detection of stavudine concentrations in plasma of HIV-infected patients taking zidovudine.

F. D. De Rosa, G. di Perri, M. Boffito, 2004, AIDS.

A new assay based on solid-phase extraction procedure with LC-MS to measure plasmatic concentrations of tenofovir and emtricitabine in HIV infected patients.

G. di Perri, A. D’Avolio, M. Siccardi, 2008, Journal of chromatographic science.

Simultaneous Quantification of Linezolid, Rifampicin, Levofloxacin, and Moxifloxacin in Human Plasma Using High-Performance Liquid Chromatography With UV

F. D. De Rosa, A. D’Avolio, M. Siccardi, 2009, Therapeutic drug monitoring.

Acute HIV-1 infection: clinical and biological study of 12 patients.

G. Palestro, A. Sinicco, P. Caramello, 1990, Journal of acquired immune deficiency syndromes.

Pharmacokinetics and hepatotoxicity of lopinavir/ritonavir in non-cirrhotic HIV and hepatitis C virus (HCV) co-infected patients.

F. D. De Rosa, G. di Perri, A. D’Avolio, 2005, The Journal of antimicrobial chemotherapy.

Pneumocystis carinii in a patient with pulmonary sarcoidosis and idiopathic CD4+ T lymphocytopenia.

A. Maiello, R. Raiteri, A. Sinicco, 1996, Thorax.

A simple UHPLC-PDA method with a fast dilute-and-shot sample preparation for the quantification of canrenone and its prodrug spironolactone in human urine samples.

F. Favata, G. di Perri, F. Veglio, 2018, Journal of pharmacological and toxicological methods.

A LC-MS method to quantify tenofovir urinary concentrations in treated patients.

Stefano Bonora, Andrea Calcagno, G. di Perri, 2015, Journal of pharmaceutical and biomedical analysis.

Coinfection and superinfection of hepatitis B virus in patients infected with human immunodeficiency virus: no evidence of faster progression to AIDS.

R. Raiteri, A. Sinicco, M. Sciandra, 1997, Scandinavian journal of infectious diseases.

Seroconversion to HBV associated with seroconversion to HIV in a cohort of intravenous drug misusers in Turin, Italy

R. Raiteri, A. Sinicco, R. Fora, 1995, European Journal of Epidemiology.

Intracellular accumulation of atazanavir/ritonavir according to plasma concentrations and OATP1B1, ABCB1 and PXR genetic polymorphisms.

G. di Perri, A. Calcagno, A. D’Avolio, 2014, The Journal of antimicrobial chemotherapy.

HPLC-MS method for the simultaneous quantification of the new HIV protease inhibitor darunavir, and 11 other antiretroviral agents in plasma of HIV-infected patients.

G. di Perri, A. D’Avolio, M. Siccardi, 2007, Journal of chromatography. B, Analytical technologies in the biomedical and life sciences.

An HPLC-PDA Method for the Simultaneous Quantification of the HIV Integrase Inhibitor Raltegravir, the New Nonnucleoside Reverse Transcriptase Inhibitor Etravirine, and 11 Other Antiretroviral Agents in the Plasma of HIV-Infected Patients

A. D’Avolio, M. Siccardi, S. Bonora, 2008, Therapeutic drug monitoring.

A simple and sensitive assay for determining plasma tipranavir concentration in the clinical setting by new HPLC method.

G. di Perri, A. D’Avolio, M. Siccardi, 2007, Journal of chromatography. B, Analytical technologies in the biomedical and life sciences.

Development and validation of a useful HPLC-UV method for quantification of total and phosphorylated-ribavirin in blood and erythrocytes of HCV+ patients.

G. di Perri, A. Calcagno, A. de Nicolò, 2012, Journal of pharmaceutical and biomedical analysis.

Validation of liquid/liquid extraction method coupled with HPLC-UV for measurement of ribavirin plasma levels in HCV-positive patients.

G. di Perri, A. D’Avolio, M. Siccardi, 2006, Journal of chromatography. B, Analytical technologies in the biomedical and life sciences.

Association of a single-nucleotide polymorphism in the pregnane X receptor (PXR 63396C-->T) with reduced concentrations of unboosted atazanavir.

S. Khoo, G. di Perri, A. Owen, 2008, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Negative Predictive Value of IL28B, SLC28A2, and CYP27B1 SNPs and Low RBV Plasma Exposure for Therapeutic Response to PEG/IFN-RBV Treatment

M. Rizzetto, G. di Perri, A. Calcagno, 2012, Therapeutic drug monitoring.

Pre-ART HIV-1 DNA in CD4+ T cells correlates with baseline viro-immunological status and outcome in patients under first-line ART

A. d’Arminio Monforte, F. Ceccherini‐Silberstein, G. Ippolito, 2018, The Journal of antimicrobial chemotherapy.

Is physician assessment of alcohol consumption useful in predicting risk of severe liver disease among people with HIV and HIV/HCV co-infection?

A. d’Arminio Monforte, F. Ceccherini‐Silberstein, G. Ippolito, 2019, BMC Public Health.

Low-frequency drug-resistant HIV-1 and risk of virological failure to first-line NNRTI-based ART: a multicohort European case–control study using centralized ultrasensitive 454 pyrosequencing

Karin J. Metzner, Huldrych F. Günthard, E. Nicastri, 2014, The Journal of antimicrobial chemotherapy.

Risk of developing AIDS after primary acute HIV-1 infection.

A. Sinicco, R. Fora, P. Caramello, 1993, Journal of acquired immune deficiency syndromes.

Serum cytokine profiles in acute primary HIV-1 infection and in infectious mononucleosis.

A. Sinicco, M. Sciandra, C. Martini, 1996, Clinical immunology and immunopathology.

Development and validation of a simultaneous extraction procedure for HPLC-MS quantification of daptomycin, amikacin, gentamicin, and rifampicin in human plasma

A. D’Avolio, M. Siccardi, S. Garazzino, 2010, Analytical and bioanalytical chemistry.

Switching to dual/monotherapy determines an increase in CD8+ in HIV-infected individuals: an observational cohort study

A. d’Arminio Monforte, F. Ceccherini‐Silberstein, G. Ippolito, 2018, BMC Medicine.

Identifying recent HIV infections using the avidity index and an automated enzyme immunoassay.

C. Galli, P. Pezzotti, G. Rezza, 2003, Journal of acquired immune deficiency syndromes.

Is the clinical course of HIV-1 changing? Cohort study

R. Raiteri, A. Sinicco, R. Fora, 1997, BMJ.

Single-nucleotide polymorphisms ABCB1 3435C>T, 1236C>T and CYP2B6 516G>T influence plasma concentrations of Efavirenz (EFV).

A. Calcagno, A. D’Avolio, M. Siccardi, 2010 .

HPLC-MS method for the quantification of nine anti-HIV drugs from dry plasma spot on glass filter and their long term stability in different conditions.

G. di Perri, A. D’Avolio, M. Siccardi, 2010, Journal of pharmaceutical and biomedical analysis.

The use of trough ribavirin concentration to predict sustained virological response and haematological toxicity in HIV/HCV-co-infected patients treated with ribavirin and pegylated interferon.

G. di Perri, A. D’Avolio, M. Siccardi, 2008, The Journal of antimicrobial chemotherapy.

2002 SLC28A2 65C>T PREDICT SUSTAINED VIROLOGICAL RESPONSE IN PATIENTS WITH HEPATITIS C TREATED WITH INTERFERON AND RIBAVIRIN, CONSIDERING ALL HCV GENOTYPE AND GENOTYPE 1/4

M. Rizzetto, A. Calcagno, A. D’Avolio, 2010 .

Unexpected drug–drug interaction between tipranavir/ritonavir and enfuvirtide

G. di Perri, A. Calcagno, A. D’Avolio, 2006, AIDS.

Nevirapine Plasma Exposure Affects both Durability of Viral Suppression and Selection of Nevirapine Primary Resistance Mutations in a Clinical Setting

F. D. De Rosa, G. di Perri, M. Boffito, 2005, Antimicrobial Agents and Chemotherapy.

Tipranavir (TPV) Genotypic Inhibitory Quotient Predicts Virological Response at 48 Weeks to TPV-Based Salvage Regimens

G. di Perri, A. Calcagno, A. D’Avolio, 2007, Antimicrobial Agents and Chemotherapy.

First‐line antiretroviral therapy with efavirenz plus tenofovir disiproxil fumarate/emtricitabine or rilpivirine plus tenofovir disiproxil fumarate/emtricitabine: a durability comparison

A. d’Arminio Monforte, F. Ceccherini‐Silberstein, A. Lazzarin, 2018, HIV medicine.

Intracellular accumulation of ritonavir combined with different protease inhibitors and correlations between concentrations in plasma and peripheral blood mononuclear cells.

G. di Perri, A. Calcagno, A. D’Avolio, 2013, The Journal of antimicrobial chemotherapy.

Incidence and progression to cirrhosis of new hepatitis C virus infections in persons living with human immunodeficiency virus.

A. d’Arminio Monforte, F. Ceccherini‐Silberstein, G. Ippolito, 2017, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.

Pneumocystis carinii in a patient with pulmonary sarcoidosis and idiopathic CD4+ T lymphocytopenia.

A. Maiello, R. Raiteri, A. Sinicco, 1996, Thorax.

A Simple and Fast Method for Quantification of Ertapenem using Meropenem as Internal Standard in Human Plasma in a Clinical Setting

F. D. De Rosa, G. di Perri, A. D’Avolio, 2008, Therapeutic drug monitoring.

Inosine Triphosphatase Polymorphisms and Ribavirin Pharmacokinetics as Determinants of Ribavirin-Associate Anemia in Patients Receiving Standard Anti-HCV Treatment

M. Rizzetto, G. di Perri, A. Calcagno, 2012, Therapeutic drug monitoring.

Increased risk of virologic failure to the first antiretroviral regimen in HIV-infected migrants compared to natives: data from the ICONA cohort.

A. d’Arminio Monforte, F. Ceccherini‐Silberstein, M. Capobianchi, 2014, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.